Doctors back anti-smoking drug

Share this article with friends

EmailEmail Copy LinkCOPY

THE Royal Australian College of GPs (RACGP) backs a new smoking cessation drug, Cytisine, as it awaits approval from the Therapeutic Goods Administration. RACGP President Dr Nicole Higgins emphasizes its potential impact amid upcoming removals of nicotine replacement therapy options from public schemes. Highlighting Cytisine’s proven efficacy and minimal side effects, she urges support for its scheduling. With concerns over rising nicotine use, especially among youth, Dr Higgins advocates for expanded cessation tools while encouraging individuals to consult their GPs for tailored support in quitting.

Article Details

Published in

Editors Picks